Department of Chemistry, Perm State University, Bukireva St. 15, 614990 Perm, Russia.
Department of Biology, Perm State University, Bukireva St. 15, 614990 Perm, Russia.
Molecules. 2023 Oct 14;28(20):7095. doi: 10.3390/molecules28207095.
The treatment of many bacterial and fungal infections remains a problem due to increasing antibiotic resistance and biofilm formation by pathogens. In the present article, a methodology for the chemoselective synthesis of 2-(1-indol-3-yl)-1-benzo[]imidazole derivatives is presented. We report on the antimicrobial activity of synthesized 2-(1-indol-3-yl)-1-benzo[]imidazoles with significant activity against ATCC 25923, ATCC 43300 (MRSA), (mc(2)155/ATCC 700084), and ATCC 10231. High activity against staphylococci was shown by indolylbenzo[]imidazoles and (minimum inhibitory concentration (MIC) < 1 µg/mL) and and (MIC 3.9-7.8 µg/mL). A low MIC was demonstrated by 2-(1-indol-3-yl)-1-methyl-1-benzo[]imidazole () against and against (3.9 µg/mL and 3.9 µg/mL, respectively). 2-(5-Bromo-1-indol-3-yl)-6,7-dimethyl-1-benzo[]imidazole () showed a low MIC of 3.9 µg/mL against . Compounds , , , and exhibited excellent antibiofilm activity, inhibiting biofilm formation and killing cells in mature biofilms. Molecular docking analysis identified three potential interaction models for the investigated compounds, implicating (p)ppGpp synthetases/hydrolases, FtsZ proteins, or pyruvate kinases in their antibacterial action mechanism.
由于病原体对抗生素的耐药性增加和生物膜的形成,许多细菌和真菌感染的治疗仍然是一个问题。在本文中,提出了一种化学选择性合成 2-(1-吲哚-3-基)-1-苯并[]咪唑衍生物的方法。我们报告了合成的 2-(1-吲哚-3-基)-1-苯并[]咪唑的抗菌活性,它们对 ATCC 25923、ATCC 43300(MRSA)、(mc(2)155/ATCC 700084)和 ATCC 10231 具有显著的活性。具有吲哚基苯并[]咪唑的化合物和 (最低抑菌浓度 (MIC) < 1 µg/mL)和 (MIC 3.9-7.8 µg/mL)对葡萄球菌表现出高活性。2-(1-吲哚-3-基)-1-甲基-1-苯并[]咪唑 () 对 和 (MIC 分别为 3.9 µg/mL 和 3.9 µg/mL)的 MIC 较低。2-(5-溴-1-吲哚-3-基)-6,7-二甲基-1-苯并[]咪唑 () 对 显示出较低的 MIC(3.9 µg/mL)。化合物 、 、 、 和 表现出优异的抗生物膜活性,抑制生物膜形成并杀死成熟生物膜中的细胞。分子对接分析确定了三种潜在的相互作用模型,涉及(p)ppGpp 合酶/水解酶、FtsZ 蛋白或丙酮酸激酶在其抗菌作用机制中的作用。